Despite technological innovation and expanded access to coverage, Americans’ satisfaction with their healthcare has been largely stagnant for the past 20 years. There is a growing gap between cutting-edge care and what the average person receives when they interact with the healthcare system. This year’s conference will focus on a new wave of innovation that seeks to transform the healthcare experience by improving quality, enhancing access, and increasing affordability.
8:00 am - 9:00 am: Registration and Breakfast
9:00 am - 9:15 am: Welcome Address
9:15 am - 10:00 am: Opening Keynote
10:15 am - 11:15 am: Concurrent Panels
Panel A | The Promise of Digital Health
Panel B | Investing in the Convergence of Healthcare and Technology
11:30 am - 12:30 pm: Lunch and Networking
12:30 pm - 1:15 pm: Lunch Keynote
1:30 pm - 2:30 pm: Concurrent Panels
Panel A | Closing the Gender Gap in Healthcare Innovation
Panel B | So What Will it Cost? Transparency and the Patient Experience
2:30 pm - 4:00 pm: Networking Reception & Startup Fair
For more details, visit our conference website here: https://groups.chicagobooth.edu/fthealthcare/2019/
University Club of Chicago
76 E Monroe St, Chicago, IL 60603, United States
Jeff Elton, PhD
Chief Executive Officer
Concerto Health AI
Jeff Elton, Ph.D. is CEO, Concerto HealthAI (“CHAI”), a Precision Oncology and AI Solutions company, partnered with the American Society of Clinical Oncology’s CancerLinQ program, and healthcare providers across the U.S. CHAI develops engineered Real-world data products aligned to specific use-cases, for example regulatory submissions, post-approval outcomes studies, market access initiatives, and patient-adherence solutions. CHAI’s Real-world data products are deployed within the industry’s leading Clinical Cloud and AI enabled microservices applications suite, augmented by AI Models to streamline and speed analyses, medical innovations, and patient-centric solutions.
Prior to CHAI, Dr. Elton was Managing Director Accenture Strategy/Patient Health focused on building the next generation of value and outcomes-centric business models for healthcare organizations and life science companies. He is the co-author of the widely cited book, Healthcare Disrupted (Wiley, 2016).
Jeff has over 25 years of experience as a global executive and consultant in the healthcare and life sciences. Jeff previously was Senior Vice President of Strategy and Global Chief Operating Officer at Novartis Institutes of BioMedical Research, Inc.; founding CEO of an oncology molecular diagnostics and therapeutic pathways company; and founding board member and senior advisor to several early stage companies in Artificial Intelligence, Digital Pathology, Parkinson's Disease treatment, protein therapeutics, diabetes, oncology therapeutics, and precision medicine/oncology diagnostics.
Jeff is currently a board member of the Massachusetts Biotechnology Council. Jeff is former partner with McKinsey & Company and adjunct faculty at Boston University, Questrom School of Business, in Health Sector Management. Jeff has a Ph.D. and M.B.A. from The University of Chicago, Booth School of Business.
Vice President of Corporate Development
Richard Lindsay-Jones leads Humana’s Corporate Development team. Richard is a key member of Humana’s Strategy team and is responsible for the identification, assessment, negotiation and closing of all mergers, acquisitions, and strategic partnerships. Richard joined Humana in April 2018.
Before joining Humana, Richard spent 18 years in Investment Banking and Consulting and most recently came from Morgan Stanley’s Investment Banking division. At Morgan Stanley, he provided advice to clients on strategic and M&A topics including identifying and sourcing opportunities, evaluating strategic rationale, valuation and returns, negotiating and executing transactions, and evaluating optimal financing structures. Richard has advised on a broad range of transaction types, including M&A, divestitures, initial public offerings and debt financings.
Before joining Morgan Stanley, Richard was an Investment Banking Vice President at Bank of America Merrill Lynch in London, UK where he was responsible for executing financing transactions, building M&A models, completing capital structure analysis, and navigating the rating agencies for dozens of clients. Prior to his Investment Banking experience, Richard worked as a strategy consultant and executed client consulting projects for Financial Institutions and Insurance clients with Diamond Management and Technology Consultants in Chicago.
Richard has a bachelor’s degree from University of Pennsylvania and a Masters of Business Administration from The University of Chicago Booth School of Business.
Vice President of Revenue Cycle
Rush University Medical Center
Denise Szalko is the Vice President, Revenue Cycle for Rush University Medical Center. Ms. Szalko has been at Rush since 2005 and in her current role since 2014.
Ms. Szalko is responsible for the strategic and operational leadership of the organization’s revenue cycle function, including registration, admitting, revenue integrity, patient billing and followup, and customer service for hospital and professional services of Rush’s employed medical group which total $1.7 billion. During her tenure in this role, Ms. Szalko led the integration of hospital and professional billing into a single business office and has achieved over $100 million in cumulative improved revenue realization through a focus on continuous improvement. Prior to being appointed to her current role, Ms. Szalko was Vice President, Financial Planning & Decision Support during which she led a number of initiatives in support of Rush’s facilities expansion, program development and cost containment efforts. Ms. Szalko is also an instructor in Rush’s Health Systems Management program.
Prior to joining Rush, Denise has 20 years experience in various financial management roles within the healthcare industry in auditing and consulting and with managed care and complex provider organizations. Denise received an MBA from the University of Chicago Booth School of Business and a BS in Commerce from DePaul University. She is a Certified Public Accountant and a member of the Healthcare Financial Management Association.
Co-Founder and Managing Director
ARCH Venture Partners
Keith Crandell is a Managing Director and Co-Founder of ARCH Venture Partners, L.P., a global seed and early stage venture capital firm focused on innovations in the life and physical sciences. ARCH Venture partners is investing its ninth fund and manages $3.2 billion. ARCH has lead, co-lead or co-founded more than two hundred companies based on leading university, corporate, national laboratory or entrepreneurial research since its start in 1986. Mr. Crandell has played a key role in the formation and initial funding round of Quanterix (QTRX), 908 Devices, Arbor Biotechnologies, Cytrellis Biosystems, Ultivue, Genturi, ALIS Corp. (acquired by Carl Zeiss SMT), Eichrom Industries (acquired by Gary Comer, Inc.), Nanophase Technologies (NANX), and Illinois Superconductor (ISCO). He is a director of Quanterix, Nanosys, Adesto Technologies, 908 Devices, Boreal Genomics, Twist Bioscience, Arbor Biotechnologies, Cytrellis Biosystems, Genturi, and Ultivue.
Keith is a board member of the Chicago History Museum, the Clean Energy Trust, the Illinois Growth and Development Fund, the Morton Arboretum and the Polsky Council at the University of Chicago. He has served as a Director of the National Venture Capital Association. Keith also serves as an Advisory Board member for the Partners Innovation Fund, the venture capital fund of the Harvard University Affiliated Hospitals and an Advisory Council member for the University of Chicago Institute for Molecular Engineering.
Keith holds an M.B.A. from The University of Chicago (Booth), an M.S. in Chemistry from the University of Texas at Arlington, and a B.S. in Chemistry and Mathematics from St. Lawrence University.
Brittany Maddox (Genelin)
Director of Operations
Brittany Genelin is the Director of Operations at ExplORer Surgical, a role she took on after holding the title of Director of Strategy and Business Development. Her primary role in the company is to lead our Clinical Operations and Customer Success teams. Through these teams, she serves ExplORer's clients from contract signing to technology implementation through ongoing usage. The Clinical Operations team, made of registered nurses and pre-medicine graduates, is focused on building strong procedural workflows and training client users on best practices of using ExplORer in the operating room, procedural suite, and in training environments. The Customer Success team ensures clients get the most out of the rich data sets that ExplORer produces by identifying insights and making that data actionable.
Ms. Genelin holds an MBA at the University of Chicago Booth School of Business, with concentrations in Finance and Entrepreneurship. In her past, she has served as an investment associate for Hyde Park Angels, sourcing and performing diligence on early-stage businesses across industries as well as advising startups on growth strategy and as a Senior Manager on Best Buy's Growth, Innovation, and Strategy Team where she led large-scale efforts in corporate strategy and pioneered the company's engagement with startups. Additionally, she built her career with Deloitte Consulting where she advised healthcare companies of all types (payers, providers, and medical device companies) on everything from data analytics to product strategy.
Gamilah Pierre, MD
Partners in Obstetrics & Women's Health
Gamilah N. Pierre, MD, MBA, FACOG is a graduate of New York University and Temple University School of Medicine. Dr. Pierre completed her residency training in Obstetrics & Gynecology at the University of Texas Health Science in Houston and later formed Partners in Obstetrics & Women’s Health with two colleagues from residency. She joined the medical staff at Silver Cross Hospital in 2002. Dr. Pierre went on to serve as the Chair of the Department of OB GYN from 2007-2015 and currently sits on many committees at the hospital.
Her professional interests include treatment of menstrual irregularities including treatment of fibroids and polyps and minimally invasive surgery. In addition she enjoys caring for low risk and high-risk obstetrical patients. She is a member of several professional societies including American Congress of Obstetricians and Gynecologists (ACOG), American Association of Gynecologic Laparoscopists (AAGL) and Midwest Institute for Robotic Surgery (MIRS). Dr. Pierre is a board certified obstetrician/gynecologist and is licensed in Illinois and Texas.
In addition to her clinical duties she is also on the Board of Directors of Girls Inc. Chicago and The Joseph Assignment Global Initiative. Through The Joseph Assignment, she has been able to use her medical training on mission trips to Ghana. And through Girls Inc, she is able to inspire and empower girls of all ages. In 2013 she received a MBA from the University of Chicago Booth School of Business.
Vice President, Corporate Venture and Innovation
Advocate Aurora Health
Dipa is the head of Corporate Ventures at Advocate Aurora Health, the 9th largest health system in the United States. She focuses her time on fund and direct investments into healthcare companies that are strategically relevant to the provider system. Dipa was formerly a Managing Director at Sandbox Industries, a Chicago-based venture capital firm which is the investment manager to the BlueCross BlueShield Venture Funds, a collaborative investment platform with over $575 million in capital and 30 Blue Plans participating.
Prior to Sandbox, Dipa was at Amgen Ventures, the corporate venture fund of Amgen. At Amgen, Dipa worked closely with the global commercial and marketing organizations to identify companies in the digital health space for their products. Dipa started her career in the Global Healthcare Group at UBS and the Healthcare Fund at Paul Capital Partners, which invested in late-stage pharmaceutical and biotechnology companies.
Dipa holds a BS from the New York University Stern School of Business and an MBA from Chicago Booth where she received the Chicago Booth Leadership Award of Distinction. Dipa is also a Kauffman Fellow.
Executive Director of Commercial Market Solutions
Blue Cross Blue Shield Association
Jodi Portnoy is Executive Director, Commercial Market Solutions at the Blue Cross and Blue Shield Association. Her team works across functional areas and BCBS Plan leadership teams to support communications, education and marketing, adoption, and measurement of BCBSA’s market solutions. With 22 years’ tenure at BCBSA, Jodi has significant subject matter expertise in the health insurance marketplace. She has led market and strategy assessments, program development and implementations, and has consulted with individual Plans to support BCBS market success, with a particular emphasis on commercial lines of business.
Outside BCBSA, Jodi sits on the Board of Directors for 2 local nonprofits: Esperanza Health Centers and the Guest House at the Illinois Medical District. She received an MBA with honors from the University of Chicago’s Booth School of Business and a Bachelor of Arts degree from Washington University in St. Louis.
Chief Operating Officer / Principal
HealthiPASS Inc / OCA Ventures
Imran joined OCA Ventures in 2010 as a member of the investment team, and brings over fifteen years of experience financing, investing, and founding early stage technology companies. He is currently the Chief Operating Officer of Health iPASS, an OCA Ventures portfolio company focused on healthcare payments.
Prior to joining OCA Ventures, Imran worked as a mobile strategy and operations analyst for PayPal Mobile where he helped launch PayPal Here in domestic retail and international markets. Additionally, Imran was a private equity associate for JMH Capital where he invested in growth equity and leveraged buyout transactions in healthcare and business services. He began his career as an investment banking analyst for William Blair.
Imran completed his MBA from the University of Chicago Booth School of Business with concentrations in Entrepreneurship and Management and received his BA in Economics from the University of Chicago. He is very active in the startup community, his mosque youth group, and enjoys spending time with his family.
Chief Executive Officer
Rachel Kohler is the CEO and co-owner of NowPow, a healthcare technology platform that helps patients access self care resources to address basic unmet needs and chronic health and social conditions. Before NowPow, she worked for 22 years for Kohler Co, a privately held family business with a portfolio spanning the plumbing, power, and hospitality sectors. She continues to serve on Kohlers Board of Directors and is a member of the Kohler Foundation. She is a trustee at the University of Chicago, the University of Chicago Medical Center, and the MacLean Center for Clinical Medical Ethics. She serves as treasurer for LPMC Foundation, a public charity supporting music education programs for youth in underserved areas of Chicago. She is also a member of the board of MAPSCorps. Prior to her position at Kohler, Rachel worked at Booz Allen & Hamilton, a management consulting firm, and at First Boston, an investment bank now known as Credit Suisse.
Rachel holds an MBA from the University of Chicago and a BA from Princeton University.
McKinsey and Company
Arshiya is an Engagement Manager in McKinsey’s Chicago office. Prior to joining the firm, Arshiya was a product manager and implementation consultant at Epic, an electronic health record software company, managing enterprise healthcare IT transformations at large provider systems and working closely with cardiologists to develop new product concepts in pediatric cardiology. While at McKinsey, she has experience working with medical device and pharmaceutical companies, national provider systems and payors on a variety of subjects including growth strategy, pricing, organizational redesign and procurement.
Arshiya has a B.A in Biology with a specialization in endocrinology from the University of Chicago and an MBA in strategy, finance and entrepreneurship from University of Chicago’s Booth School of Business. While at business school, Arshiya worked with a team to design a self-collection device for at-home cervical cancer screening for NVC.
Sunitha Sastry, MPH CPXP
Director, Experience Improvement and Innovation
University of Chicago Medicine
Sunitha Sastry is a healthcare professional with almost 20 years’ experience in health care consulting and academic medical centers, guiding organization-wide strategic, operational and patient experience initiatives. Sunitha joined the University of Chicago Medicine (UCM) from KPMG Consulting, Inc in 2004. During this time, Sunitha has had various roles in performance improvement, as a Lean Facilitator and a Pediatric Administrator in the Behavioral Sciences Division. For the past seven years, Sunitha is the Director of Experience Improvement and Innovation in the Patient Experience and Engagement Program. She has led enterprise-wide experience strategies focusing on cultivating a culture where exceptional experiences occur for everyone, every time. Through her leadership in the hArt of Medicine program, she coaches leaders in shining a light on the strengths that care team members bring into interactions to create exceptional experiences. Sunitha has a Bachelor’s of Arts from the University of Michigan-Ann Arbor, and a Masters of Public Health from Boston University. She is also a Certified Patient Experience Professional through the Patient Experience Institute and has authored numerous papers on patient experience best practices.
Director of Product Management
Cat has over 10 years of experience in strategy and product management with a focus on healthcare tech. Prior to CVS - Health, Cat was the Director of Product Management for Aetna - Digital, where she lead the strategy and launch of digital apps for provider search and price transparency. Cat has also led product management, marketing and engineering teams at Medtronic and Accenture - Healthcare.
In addition to her role at CVS Health, Cat is a member of the Minnesota Spay Neuter Assistance Program (MN SNAP) Board of Directors. Cat lives in Minneapolis with her family. She is a graduate of the College of Science and Engineering at the University of Minnesota, and received an MBA from the University of Chicago - Booth School of Business.
Lee Hasselbacher, JD
Senior Health Policy Researcher
Ci3 at The University of Chicago
Lee Hasselbacher is Senior Policy Researcher at The Center for Interdisciplinary Inquiry and Innovation in Sexual and Reproductive Health (Ci3) at The University of Chicago. Lee leads Ci3’s reproductive health policy research, collecting data and translating research findings to inform policy debates and legislation. Her research covers topics such as access to contraception and abortion, health care reform, religious refusals in health care, and consent and confidentiality for young people.
Lee is a graduate of Northwestern Pritzker School of Law, where she focused on law and social policy, and the University of Wisconsin-Madison.
Dustin Braunreiter, MD
Medical Director, Enterprise National Accounts
Health Care Service Corporation / Blue Cross & Blue Shield
Dustin is a health care leader with 15+ years' of clinical and managerial experience and health care strategy consulting experience across payer, provider, and medical device sectors. He has a proven track record of leading complex care of patients, medical education, quality improvement, research, and strategic business planning.
Dustin is currently the Medical Director of Enterprise National Accounts at Health Care Service Corporation where he manages health care expenditures through effective utilization review and cost containment while improving quality of and access to health care.
Principal, Strategic Investing,
Matty is part of the investment team for the DaVita Venture Fund. Previously, Matty led client engagements across Healthbox’s innovation consulting services. Prior to Healthbox, Matty held leadership roles at North Fork Ventures, Groupon, and Bank of America Merrill Lynch, focusing on early-stage investing, corporate finance and strategy, and securitization. Early in his career, he supported consulting engagements for healthcare providers while at Sg2.
Matty holds a BS in Biomedical Engineering from the Northwestern University, where he sits on the departmental Advisory Board, as well as an MBA from the University of Chicago Booth School of Business. Additionally, he holds a CFA Charter.
Georgios Bertos, PhD
Lead Systems Designer
Georgios is an innovative Medical Devices Leader with a proven track record of utilizing strategic thinking, business insight and hands-on technical experience to generate visionary product ideas with a focus on marketplace competitiveness. Georgios employs DFSS-centric process and teamwork-based leadership ensure quality-driven, efficient, innovative product and technology pipeline with an emphasis on market intelligence and new trends. He has extensive Systems, Biomedical, Electrical and Software R&D experience in new product development of embedded systems and innovative electromechanical medical devices.
Georgios earned his M.S. in Electrical and Computer Engineering from Northwestern, Ph.D. in Biomedical Engineering from Northwestern, and M.B.A from Chicago Booth.
Founder and Chief Executive Officer
Nathan Pelzer is the Founder and CEO of Clinify Health, a technology company that uses applied health signals to drive holistic patient care and improved health outcomes. Prior to founding Clinify, Nathan was the Head of Corporate Strategy for VillageMD, a national primary care provider organization located in Chicago.
Previous to this role Nathan spent the previous 12 years of his career in senior level positions providing strategy consulting and investment banking advisory in various aspects of the healthcare industry. Nathan has a B.S. in Finance from The University of Minnesota and an M.B.A. from the University of Chicago – Booth School of Business.
Co-Founder and Chief Executive Officer
Dane leads business development and capital raising at Markit. Previously, he spent four years as an investment banker advising on M&A and capital raises for early-stage healthcare tech companies. Several of Dane’s clients were strategically focused on helping physician offices improve administrative and operational functions with software. Much of what he learned working with these clients is leveraged in how Markit Medical approaches partnering with physician offices. Dane has an MBA from Chicago Booth.
Tamar Polonsky, MD
Physician & Researcher
Tamar Polonsky, MD, MSCI, is a general cardiologist who treats a wide range of cardiac conditions, including coronary artery disease, hypertension, hyperlipidemia (high cholesterol) and valve disease.
Dr. Polonsky also specializes in the management of heart disease in cancer patients (cardio-oncology). She works closely with oncologists and surgeons to take care of patients with preexisting heart disease and to help monitor for potential cardiac complications from chemotherapy and radiation.
Dr. Polonsky has research expertise in cardiovascular epidemiology and prevention. She has experience analyzing data from large cohort studies, with the aim of finding novel ways to predict a person's risk of developing heart disease.
Senior Director and Chief of Staff
Kalli White is Chief of Staff at Maven, the virtual clinic dedicated to women’s and family health that was recently named one of Fast Company’s “10 Most Innovative Healthcare Companies.” Reporting to the founder and CEO, Kalli is responsible for growth-oriented strategic initiatives, internal company communications, and overall organizational development. Kalli previously managed marketing and growth teams at a startup called Maker’s Row. Outside of work, Kalli is active in the NYC running community and co-founder of Distance Project NYC, an elite all-women’s running team. Kalli received her BA from Colby College in Government.
Ross is a Senior Manager in Accenture's Healthcare Management Consulting practice. Ross has shaped and delivered engagements that have generated $250M+ in revenue and $50M+ in EBITDA gains through operating model redesign, cost takeout, and technology enhancements. The majority is Ross’s experience has focused on optimizing the patient financial experience. Ross received his MBA from the University of Chicago and his undergraduate degree from Notre Dame.